Dr. Yarur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8730 Alden Dr. Thalians 2E
Los Angeles, CA 90048Phone+1 414-955-6830Fax+1 414-955-6214
Summary
- Dr. Andres Yarur is a gastroenterologist at the IBD center of Cedars Sinai Medical Center. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 14 years. Performs clinical and translational research in Crohn's disease and ulcerative colitis while caring for patients with these chronic conditions.
Education & Training
University of ChicagoFellowship, Gastroenterology, 2017
University of Miami/Jackson Health SystemFellowship, Gastroenterology, 2011 - 2014- University of Miami/Jackson Health SystemResidency, Internal Medicine, 2008 - 2011
University of Miami Leonard M. Miller School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2022 - 2026
WI State Medical License 2015 - 2023
IL State Medical License 2014 - 2020
FL State Medical License Active through 2014- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC Start of enrollment: 2017 May 18
Publications & Presentations
PubMed
- Etrasimod as a Monotherapy or With Concomitant Use of Corticosteroids and/or Aminosalicylates: Results From the ELEVATE UC Clinical Program.Andres J Yarur, Michael V Chiorean, Jessica R Allegretti, Raymond K Cross, Christina Ha
Inflammatory Bowel Diseases. 2024-12-13 - 1 citationsImpact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials.Séverine Vermeire, Bruce E Sands, Laurent Peyrin-Biroulet, Geert R D'Haens, Julian Panés
Journal of Crohn's & Colitis. 2024-11-04 - 1 citationsEtrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical Programme.Miguel Regueiro, Britta Siegmund, Andres J Yarur, Flavio Steinwurz, Krisztina B Gecse
Journal of Crohn's & Colitis. 2024-10-15
Journal Articles
- Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel DiseasesRyan Ungaro, Daniel J Stein, Andres J Yarur, Amir Patel, Marla Dubinsky, Digestive Diseases and Sciences
Press Mentions
$3M Grant Awarded to Examine Ozempic Effect on Crohn's DiseaseDecember 13th, 2024- Helmsley Charitable Trust Awards $3 Million Grant to Research Epithelial Healing in Crohn’s DiseaseDecember 12th, 2024
- Cedars-Sinai Experts Share Advances in Gastroenterology Care at ACG 2024October 25th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
